BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...in 18 patients; increased infiltration of inflammatory cells; "may provide a clinically significant survival" 2019 YooYoung Pharmaceutical Co. Ltd....
BioCentury | Mar 11, 2013
Product Development

Neomics' new tricks

...Yuhan Corp. is developing a drug using the KRS diagnostic; Ildong Pharmaceutical Co. Ltd. and Yooyoung Pharmaceutical Co. Ltd....
...South Korea Seoul National University , Seoul, South Korea Yuhan Corp. , Seoul, South Korea Yooyoung Pharmaceutical Co. Ltd....
Items per page:
1 - 2 of 2
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...in 18 patients; increased infiltration of inflammatory cells; "may provide a clinically significant survival" 2019 YooYoung Pharmaceutical Co. Ltd....
BioCentury | Mar 11, 2013
Product Development

Neomics' new tricks

...Yuhan Corp. is developing a drug using the KRS diagnostic; Ildong Pharmaceutical Co. Ltd. and Yooyoung Pharmaceutical Co. Ltd....
...South Korea Seoul National University , Seoul, South Korea Yuhan Corp. , Seoul, South Korea Yooyoung Pharmaceutical Co. Ltd....
Items per page:
1 - 2 of 2